Jefferies analyst Cui Cui maintained a Buy rating on Wuxi Biologics (Cayman) (WXIBF – Research Report) today and set a price target of ...
6d
Vietnam Investment Review on MSNWuXi Biologics Posts Strong 2024 Results Forecasts Rapid Growth in 2025Inc. ("WuXi Biologics" or "the Group", stock code: 2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO) service company offering end-to-end solutions for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results